Key facts
- This page summarizes Joseph W. LaPlume's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2026, 16:38.
Joseph W. LaPlume - 10 Aug 2026 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- EVP, Corp Strategy & Develop
- Issuer ticker
- CRL
- Reported as of
- 10 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2026, 16:38:49 UTC
- Prior SEC filing
- 02 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph W. LaPlume
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph W. LaPlume filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 11 Aug 2026.
Change
- Previous filing in this sequence was filed on 02 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001767215
Primary reporting owner
LaPlume Joseph W
- Relationship
- EVP, Corp Strategy & Develop
- Address
- C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON
- Signature
- /s/ Joseph W. LaPlume
- Signature date
- 11 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Gift
- Transaction value
- Shares
- -257
- Change %
- -0.82%
- Price
- $0.000000*
- Shares after
- 31,041
- Date
- 10 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.